Combination checkpoint inhibition, angiogenic inhibition and hepatic artery infusion chemotherapy for disease control of...
Editorial Commentary
Combination checkpoint inhibition, angiogenic inhibition and hepatic artery infusion chemotherapy for disease control of advanced hepatocellular carcinoma